Clinical trial success is a delicate balance of research,
relationships and results. At Metroplex Clinical Research Center,
we've found the formula.
- 23 Years of Experience
- A Track Record of Achievement
- A Team of Top Doctors
- State-of-the-Art Research Facilities
Areas of experience include:
- Rheumatology
- Rheumatoid arthritis
- Osteoarthritis
- Osteoporosis
- Lupus
- Cardiovascular disease
- Hypercholesterolemia
- Hypertension
- Sleep disorders
- Smoking cessation
- Obesity
- Dermatology
- Psoriasis
- Migraine
- Vaccine
- HIV Vaccine
- Flu Vaccine
MCRC staff includes board certified rheumatologists, experienced
coordinators, recruitment specialists, regulatory specialists, and
laboratory technicians.
Comprehensive services include:
- Ten physician investigators
- Three physician extenders, two nurse practitioners and one
physician's assistant
- Full-service X-ray department including bone density
testing
- Onsite CLIA-certified laboratory
- Onsite infusion unit
Roy M. Fleischmann, M.D.
Medical Director
Dr. Fleischmann is a clinical professor in the Department of
Internal Medicine at the University of Texas Southwestern Medical
Center (UTSMC) and is in private practice at Rheumatology
Associates in Dallas. He has served as chief of the Division of
Rheumatology at UTSMC University Hospitals’ St. Paul, Dallas, since
1978. Dr. Fleischmann has been the co-medical director of Radiant
Research in Dallas, since 1999.
He received his Doctor of Medicine (M.D.) from State University
of New York, Downstate Medical Center, in 1969, before completing
his residency in internal medicine at the Mt. Sinai Hospital, New
York City, and his fellowship in rheumatology at the College of
Physicians and Surgeons, Columbia University, New York City.
He is a diplomate of the American Board of Internal Medicine and
is a fellow of the American College of Rheumatology. He has served
on the finance committee of the American College of Rheumatology
and the fund-raising committee of the Research and Education
Foundation (REF) of the American College of Rheumatology. He has
previously served on the board of directors and the executive
committee of the North Texas Arthritis Foundation. He has been
president of the Texas Rheumatism Society and has sat on the
governing board of the Texas Rheumatism Association. He has been a
consultant to pharmacological companies in the areas of trial
design, protocol development and CME development. He is a member of
the Inflammation Research Association, the Associates of Clinical
Pharmacology and the Drug Information Association. He has been
involved in many clinical trials on treatments for osteoarthritis
and rheumatoid arthritis and has published more than 60
peer-reviewed articles in these areas. Dr. Fleischmann has been
voted one of the Best Doctors in Dallas as well as
Texas Super Doctors.
Stanley B. Cohen, M.D.
Medical Director
Dr. Cohen is a clinical professor in the Department of Internal
Medicine at the University of Texas Southwestern Medical School
(UTSMS) and is in private practice at Rheumatology Associates in
Dallas. He is associate director of the Division of Rheumatology at
UTSMC University Hospitals’ St. Paul and medical director of
Metroplex Clinical Research Center in Dallas. Dr. Cohen is actively
involved in teaching rheumatology fellows and residents during
their clinical rotations in the office.
Dr. Cohen graduated Phi Beta Kappa with a degree in biology from
the University of Virginia and received his Doctor of Medicine
(M.D.) with honors from the University of Alabama School of
Medicine in Birmingham, where he was inducted into Alpha Omega
Alpha Honor Medical Society. He then completed an internship and
residency in internal medicine at Parkland Memorial Hospital in
Dallas and a fellowship in rheumatology at St. Paul Medical
Center/Southwestern Medical School in Dallas. Dr. Cohen is board
certified in internal medicine with sub-specialty certification in
rheumatology.
A fellow of the American College of Rheumatology, Dr. Cohen was
past-chairman of the board of the North Texas Arthritis Foundation
(AF) and was honored with the AF Medical Profession Award in 1994.
He was president of the American College of Rheumatology Research
and Education Foundation from 2000 to 2002 and served on the board
of directors of the American College of Rheumatology from 2001 to
2004. He was previously on the Medical Advisory Board of Directors
of the Harold C. Simmons Arthritis Center at the University of
Texas Southwestern Medical School. Dr. Cohen is presently secretary
treasurer of the American College of Rheumatology and a member of
the University of Texas Southwestern Medical School CME Executive
Committee.
He has served as a consultant to the pharmaceutical industry on
protocol development in rheumatoid arthritis, glucocorticoid
induced osteoporosis and disease modification in osteoarthritis, as
well as medical advisory boards and data safety monitoring
committees. Dr. Cohen has been an author or co-author of book
chapters, articles and abstracts that have been published in many
leading journals and presented at national and international
medical and scientific symposia. He also received the Howard. C.
Coggeshall Lifetime Achievement Service Award from the North Texas
Arthritis Foundation in 2006 for longtime support of the Foundation
and its programs.
The center employs certified and trained coordinators,
recruitment specialists, regulatory specialists and laboratory
technicians as well as a distinguished contingent of nine board
certified rheumatologists. Medical directors Roy M. Fleischmann,
M.D., and Stanley B. Cohen, M.D., have 50 years of combined
clinical research experience and, between them, have published 100
scientific papers and co-authored four medical books. They are
lecturers on the subjects of research and treatment of arthritis
and osteoporosis and serve as advisors to major pharmaceutical
companies.
The MCRC database contains names of more than 3,000 healthy
subjects and more than 20,000 individuals who have participated in
clinical research studies or expressed an interest in
participation.
